Dr. Reddy's Laboratories
164 hedge funds and large institutions have $1.24B invested in Dr. Reddy's Laboratories in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 64 reducing their positions, and 12 closing their positions.
92% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 12
5% more funds holding
Funds holding: 156 → 164 (+8)
1.93% more ownership
Funds ownership: 80.53% → 82.46% (+1.9%)
0% less capital invested
Capital invested by funds: $1.24B → $1.24B (-$802K)
10% less call options, than puts
Call options by funds: $308K | Put options by funds: $344K
31% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 64
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| 1 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
+$32.5M |
| 2 |
JP Morgan Chase
New York
|
+$17.4M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
+$11.9M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$10.9M |
| 5 |
O
OppenheimerFunds
New York
|
+$4M |
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$22.8M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$12.8M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$7.46M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.45M |
| 5 |
Jane Street
New York
|
-$4.16M |
RDY Hedge Fund Activity: Q4 2016 in Review
164 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2016, worth a combined $1.24B — down 0.06% from $1.24B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new RDY positions and 12 closed out — a net gain of 11 holders — while 44 added to existing stakes and 64 trimmed.
The largest buyer was Commonwealth Bank of Australia, adding an estimated $32.5M. The largest seller was AQR Capital Management, cutting an estimated $22.8M.
- 164 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2016, up from 156 in Q3 2016.
- Funds reported $1.24B of Dr. Reddy's Laboratories stock for Q4 2016, down 0.06% quarter-over-quarter.
- 23 funds opened new Dr. Reddy's Laboratories positions in Q4 2016 and 12 closed out, a net change of +11 holders.
- The largest Dr. Reddy's Laboratories buyer in Q4 2016 was Commonwealth Bank of Australia, an estimated $32.5M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2016 was AQR Capital Management, an estimated $22.8M sold.
Based on aggregated 13F filings for Q4 2016.